Multi-spectral quantum dot-based retinal imaging of molecular expression in vivo
基于多光谱量子点的体内分子表达视网膜成像
基本信息
- 批准号:7351806
- 负责人:
- 金额:$ 18.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:Acridine OrangeAdhesionsAnimal Disease ModelsAnimal ModelAntibodiesArteriesAsthmaAtherosclerosisBindingBiologicalBiological MarkersBloodBlood CirculationBlood PlateletsBlood VesselsCD31 AntigensCell Adhesion MoleculesCell Culture SystemCell membraneCell surfaceCellsCharacteristicsCodeComplexCultured CellsCytotoxic T-LymphocytesDetectionDevelopmentDiabetes MellitusDiagnosticDiagnostic ProcedureDiseaseDisease ProgressionDyesE-SelectinEarly identificationEndothelial CellsEndotheliumEtiologyEventExtravasationEyeFluorescenceFluorescence MicroscopyFluorescent ProbesImageImaging TechniquesImmune responseIn VitroIndividualInflammationInflammation MediatorsInflammatoryInflammatory ResponseInjection of therapeutic agentIntercellular adhesion molecule 1InvasiveLabelLaboratoriesLeukocyte RollingLeukocyte TraffickingLeukocytesMalignant NeoplasmsMediator of activation proteinMethodologyMethodsMicrocirculationModalityModelingMolecularMolecular ProbesMonitorMonoclonal AntibodiesNanotechnologyNoiseNumbersOpticsPathologyPharmaceutical PreparationsPlayPolymersPopulationProcessPropertyProtein EngineeringQuantum DotsRadiolabeledRattusRelative (related person)ResearchResistanceResolutionRetinaRetinalRoleSignal TransductionSiteSourceSpecificitySpeedStreptozocinSurfaceSurface AntigensT-LymphocyteTechniquesTechnologyTherapeuticTherapeutic InterventionTimeTissuesTracerTreatment EfficacyTumor AntigensUp-RegulationValidationVascular Cell Adhesion Molecule-1VeinsWorkangiogenesisantibody conjugatebasecell typecharge coupled device cameraconceptdesigndesirediabeticdiabetic ratfluorescence imagingfluorescence microscopefluorophoreimmunogenicityin vivointercellular cell adhesion moleculeinterestlight intensitymolecular dynamicsmolecular imagingmonocytenanocrystalnanoprobeneutrophiloptical imagingquantumradiotracerresearch studyresidenceresponsesizesurface coatingtime usetissue preparationtooluptakevascular inflammation
项目摘要
DESCRIPTION (provided by applicant): Undesirable provocation of the inflammatory response is a detrimental feature of numerous diseases such as diabetes, atherosclerosis, and asthma and thus impacts a significant population. Current strategies utilized to identify key markers of inflammatory disease at the cellular and molecular level have often been centered on in vitro cell culture studies or analyses of tissue excised from animal models of disease. In this proposal we describe the development of a platform for the real-time, in vivo analysis of multiple cellular and molecular mediators of inflammation in diseased animal models using quantum dot nanocrystals and retinal fluorescence microscopy. Our design differs from previous approaches to study inflammation in vivo in that it is enabled by the harnessing of unique and highly-desirable optical properties conferred to quantum dots. These properties include higher quantum efficiency relative to conventional dyes, a resistance to fading, narrow and size-tunable emission spectra all excitable by one wavelength, and amenability to surface engineering of proteins and polymers for optimum stability and targeting. The second enabling technology is our laboratory expertise in in vivo retinal fluorescence imaging which provides unique continuous optical accessibility to the in vivo vasculature. To validate the potential of our proposed technique, in Aim 1 we seek to optimize an imaging modality / nanoprobe design to simultaneously detect the therapeutically-significant biomarkers of inflammation ICAM-1, VCAM-1, PECAM-1, and E-selectin, and to observe their relative molecular expression levels in the retinal vasculature in a rat model of diabetes. Furthermore, we seek to adapt the probe/fluorescence imaging design established in Aim 1 to track multiple leukocyte subsets in real time in vivo in the same animal model. Our preliminary work demonstrates the potential of this technique for the specific labeling and in vivo detection of the endothelial surface markers ICAM-1, VCAM-1 and PECAM-1 in vivo, as well as moving, in vivo-labeled neutrophils in the retinal circulation, with high spatial and temporal resolution and high signal to background ratios. A highlight of our preliminary studies was the first in vivo validation of VCAM-1 and ICAM-1 upregulation in diabetes. This technology has the potential to elucidate complex, cellular and molecular events as they occur in real-time not only in inflammation, but in other diseases such as cancer and ocular disorders as well.
描述(由申请人提供):炎症反应的不良刺激是糖尿病、动脉粥样硬化和哮喘等多种疾病的有害特征,因此影响了大量人群。目前用于在细胞和分子水平上确定炎症性疾病的关键标志物的策略通常集中在体外细胞培养研究或对从疾病动物模型中切除的组织进行分析。在这项建议中,我们描述了一个平台的开发,用于使用量子点纳米晶体和视网膜荧光显微镜对疾病动物模型中的多种细胞和分子炎症介质进行实时、活体分析。我们的设计与以前研究体内炎症的方法不同,因为它是通过利用赋予量子点的独特和高度理想的光学特性来实现的。这些特性包括比传统染料更高的量子效率,抗衰落,发射光谱窄且大小可调,均可由一个波长激发,以及可用于蛋白质和聚合物的表面工程,以实现最佳稳定性和靶向性。第二项使能技术是我们在活体视网膜荧光成像方面的实验室专业知识,它为体内血管系统提供了独特的连续光学访问。为了验证我们建议的技术的潜力,在目标1中,我们试图优化成像模式/纳米探针设计,以同时检测具有治疗意义的炎症生物标记物ICAM-1、VCAM-1、PECAM-1和E-选择素,并观察它们在糖尿病大鼠模型视网膜血管中的相对分子表达水平。此外,我们试图采用目标1中建立的探针/荧光成像设计,在同一动物模型中实时跟踪体内的多个白细胞亚群。我们的初步工作表明,该技术具有高时空分辨率和高信本比的潜在潜力,用于体内特异性标记和在体检测内皮表面标记ICAM-1、VCAM-1和PECAM-1,以及视网膜循环中运动的、在体标记的中性粒细胞。我们初步研究的一个亮点是首次在体内验证VCAM-1和ICAM-1在糖尿病中的上调。这项技术有可能阐明复杂的、细胞和分子事件,因为它们不仅在炎症中实时发生,而且在癌症和眼疾等其他疾病中也发生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frederick R Haselton其他文献
Frederick R Haselton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Frederick R Haselton', 18)}}的其他基金
Urine TB diagnostic by amplicon reconstruction for PCR detection of DNA fragments
通过扩增子重建进行 DNA 片段 PCR 检测诊断尿结核
- 批准号:
10385847 - 财政年份:2021
- 资助金额:
$ 18.8万 - 项目类别:
Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions
护理点 RT-PCR 系统可为 COVID-19 和呼吸道疾病决策提供信息
- 批准号:
10688237 - 财政年份:2020
- 资助金额:
$ 18.8万 - 项目类别:
Retinal Imaging of Prognostic Indicators of Atherosclerosis
动脉粥样硬化预后指标的视网膜成像
- 批准号:
7573116 - 财政年份:2009
- 资助金额:
$ 18.8万 - 项目类别:
Retinal Imaging of Prognostic Indicators of Atherosclerosis
动脉粥样硬化预后指标的视网膜成像
- 批准号:
7787531 - 财政年份:2009
- 资助金额:
$ 18.8万 - 项目类别:
Development of DNA Logic Operations for Viral Diagnostics
用于病毒诊断的 DNA 逻辑运算的开发
- 批准号:
7573152 - 财政年份:2009
- 资助金额:
$ 18.8万 - 项目类别:
Development of DNA Logic Operations for Viral Diagnostics
用于病毒诊断的 DNA 逻辑运算的开发
- 批准号:
7797468 - 财政年份:2009
- 资助金额:
$ 18.8万 - 项目类别:
Multi-spectral quantum dot-based retinal imaging of molecular expression in vivo
基于多光谱量子点的体内分子表达视网膜成像
- 批准号:
7583895 - 财政年份:2007
- 资助金额:
$ 18.8万 - 项目类别:
Multi-spectral quantum dot-based retinal imaging of molecular expression in vivo
基于多光谱量子点的体内分子表达视网膜成像
- 批准号:
7192344 - 财政年份:2007
- 资助金额:
$ 18.8万 - 项目类别:
Lagrangian detection of biomolecular interactions
生物分子相互作用的拉格朗日检测
- 批准号:
6763620 - 财政年份:2004
- 资助金额:
$ 18.8万 - 项目类别:
Lagrangian detection of biomolecular interactions
生物分子相互作用的拉格朗日检测
- 批准号:
6869526 - 财政年份:2004
- 资助金额:
$ 18.8万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 18.8万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 18.8万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 18.8万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 18.8万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 18.8万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 18.8万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 18.8万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 18.8万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 18.8万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 18.8万 - 项目类别: